<DOC>
	<DOC>NCT00314964</DOC>
	<brief_summary>The primary purpose of this study is to determine if PD-0299685 is effective and safe in the treatment of vasomotor symptoms (hot flashes / flushes) associated with menopause.</brief_summary>
	<brief_title>Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>Postmenopausal as defined by 6 months of spontaneous amenorrhea with serum FSH levels &gt;40mlU/ml and estradiol &lt; than = 25 pg/mL or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy and FSH levels &gt; 40 mlU/ml and estradiol &lt; than = 25 pg/mL Women reporting at least 50 moderate to severe vasomotor symptoms per week, recorded for seven consecutive days Aged 40 to 70 years No estrogen monotherapy or estrogen/progesterone containing drug products within applicable wash out period prior to screening Use of SERMs, clonidine within 4 weeks of screening Use of CNS active medication within 1 week of screening Use of medications (SSRI; SNRI), herbal or dietary supplements, including black cohosh, soy, phytoestrogens or over the counter agent known to possibly be effective for the treatment of vasomotor symptoms, within 4 weeks of screening Participation in clinical trial within 30 days Significant medical or psychiatric illness within past 12 months</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>